The review of the Australian guidelines on submitting medicines for inclusion on the Pharmaceutical Benefits Scheme is expected to be completed in November, after which a set of workshops will be held to help companies planning to file drugs for reimbursement under the new guidance, according to the Department of Health.
The review, which began in April 2015, is intended to ensure assessment processes at the Pharmaceutical Benefits Advisory Committee are...